• Second Round of Abstract Submission Ends: March 14, 2025
  • Early Registration Ends: March 14, 2025
Register

Submit Your Abstract

  • Home
  • Submit Your Abstract
Title
Name
Email
Organization
Telephone
City
Country
Interested In
Sessions
Attach File
Sample Abstract File
Abstract Template

Topics Covered

    Disease and Therapeutic Areas
  • Oncology
  • Infectious Diseases
  • Neurodegenerative Diseases
  • Rare Diseases
  • Degraders and Molecular Glues
  • Cellular Therapeutics
  • RNA based Therapeutics, Vaccines and Biologics

    • Clinical Trials and Manufacturing
  • Upstream and Downstream Process
  • Invitro and Invivo
  • Drug Repurposing
  • ADMET Profiling
  • SAR Studies
  • Patient Centric Drug Development
    Discovery and Development
  • AI and Machine Learning
  • Lead Optimization
  • Pharmacokinetics and Genomics
  • Protein-Protein Interactions
  • High-throughput Screening
  • Targeted Drug Delivery

    • Investment, Commercialization and Market Access
  • Drug Quality and Safety
  • Regulatory Challenges
  • Licensing and Investment
  • Market Sustainability
  • Medicinal Chemistry